New-Wave Combo Therapies: Amylin + GLP-1 (CagriSema) and “Triple” Agonists
Introduction For years, GLP-1 receptor agonists have dominated the weight-loss landscape, transforming the treatment of obesity from lifestyle counselling into a pharmacologic success story. Drugs such as semaglutide and tirzepatide have proven that hormonal manipulation of appetite and metabolism can achieve double-digit reductions in body weight, levels once thought possible only through bariatric surgery. Yet […]
